The short answer
Most private and employer health insurance plans in Florida do not cover GLP-1 medications when prescribed for weight management alone. Even when a plan technically includes these drugs, prior authorization is often required and frequently denied. The reason is straightforward: insurers classify weight loss as a cosmetic concern rather than a medical necessity, even though obesity carries serious health risks.
If you are insured in a clinic in Orlando or anywhere in Florida, you should expect to pay out of pocket for semaglutide treatment or other GLP-1 therapy unless you also have a qualifying diagnosis such as type 2 diabetes.
Why coverage is rare
Insurance companies distinguish between FDA-approved uses. Semaglutide, tirzepatide, and other GLP-1 medications are approved by the FDA for weight management, but many insurers treat that indication differently from diabetes treatment.
- Weight loss is often coded as cosmetic or elective, not medically necessary.
- Insurers cite the cost of long-term therapy and the fact that appetite returns when medication stops.
- Prior authorization requirements are designed to limit access to expensive drugs.
- Some plans exclude weight-loss drugs entirely from their formulary.
Commercial insurance varies widely across employers and plan designs. A plan offered by one large employer in Orlando may cover GLP-1 with conditions, while another employer's plan excludes it altogether. There is no single Florida rule; each plan writes its own policy.
The prior authorization maze
Even if your plan lists a GLP-1 drug on its formulary, you usually cannot simply fill a prescription. Prior authorization means the insurer must approve the prescription before you receive it.
- Your clinician submits clinical documentation to the insurance company.
- The insurer reviews your medical history, BMI, and comorbidities.
- The insurer may request additional information or deny the request outright.
- If denied, you can appeal, but appeals take time and often fail.
Insurers frequently require proof of failed diet-and-exercise attempts, a minimum BMI threshold, or documented weight-related conditions before they will consider approval. Even then, denial is common. A clinician here can help you understand what your specific plan requires, but the outcome is never expected.
Medicare and public insurance
Medicare Part D has historically excluded weight-loss drugs from coverage. Some beneficiaries have reported recent changes, but coverage remains inconsistent and is not expected.
Public health insurance in Florida does not routinely fund GLP-1 medication for weight management. If you qualify for Medicaid or another public plan, check your specific program's formulary, but do not assume coverage.
Employer plans vary widely
If you have coverage through an employer, the plan design determines whether GLP-1 is available. Some large employers have added these medications to their formularies in recent years, often with high copays or coinsurance. Others have not.
The best way to find out is to call your plan's customer service line or check your plan documents online. Ask specifically whether semaglutide or tirzepatide is covered for weight loss (not diabetes), and what prior authorization steps are required. Pricing depends on your plan's cost-sharing structure, so the same medication can cost you $50 or $500 per month depending on your coverage.
What you can do
If your insurance does not cover GLP-1 for weight loss, you have several options.
- Pay out of pocket. Many patients choose this route because it avoids the prior authorization delay and denial risk. Medication costs vary by pharmacy and formulation.
- Ask your clinician to document a qualifying diagnosis. If you have prediabetes, sleep apnea, high blood pressure, or another weight-related condition, your clinician may be able to justify the prescription on medical grounds, which can improve your chances of approval.
- Appeal a denial. If your plan denies prior authorization, you have the right to appeal. This process is lengthy but sometimes succeeds.
- Explore insurance and coverage options at your next open enrollment, if your employer offers multiple plans.
A physician-supervised program can guide you through these steps. When you meet with a clinician, bring your insurance card and plan documents so they can review your coverage with you.
The cost reality
Without insurance, medication cost for a month's supply of brand-name semaglutide or tirzepatide typically ranges from $900 to $1,500. Generic or compounded versions may be less expensive, but pricing depends on the pharmacy and the formulation.
If your plan does cover the drug, your copay or coinsurance could be $50 to $250 per month, depending on the plan's tier. Some plans require you to pay a percentage of the drug cost rather than a flat copay.
Program fees vary by clinic and the medication is billed separately; figures shown are example ranges. When you contact a clinic in Orlando for an eligibility check, ask about the total monthly cost, including both the program fee and the medication cost under your specific insurance.
Common questions answered
Will my insurance cover Ozempic or Wegovy for weight loss?
Ozempic and Wegovy are both semaglutide. Ozempic is labeled for type 2 diabetes; Wegovy is labeled for weight management. Some insurers cover Ozempic for diabetes but not Wegovy for weight loss, even though they are the same drug. This is a common coverage gap. Your plan's policy depends on the specific drug name and indication.
What if I have a BMI over 30 but no other health conditions?
Most insurers require either a BMI of 30 or higher plus a weight-related condition, or a BMI of 35 or higher with no conditions required. BMI requirements vary by plan. Even if you meet the threshold, prior authorization can still be denied.
Can I appeal if my insurance denies coverage?
Yes. You have the right to appeal any denial. Your clinician can submit additional documentation or a letter of medical necessity. Appeals take 30 to 90 days and do not always succeed, but they are worth pursuing if you believe the denial was incorrect.
Is compounded semaglutide covered by insurance?
Compounded versions are rarely covered by insurance because they are not FDA-approved brand-name drugs. Most insurers will deny coverage for compounded medications. If you choose a compounded option, expect to pay out of pocket.
What happens to my weight when I stop the medication?
Appetite returns when you stop taking GLP-1. Weight regain is common if diet and exercise habits do not change. Insurance coverage does not address this reality; it is important to understand that the medication is a tool, not a long-term treatment. Stopping medication requires a plan to maintain your progress.
Next steps
The only way to know what your plan covers is to check directly with your insurer or to have a clinician review your coverage during a consultation. Do I qualify for treatment? Start with a free eligibility assessment. A clinician can review your insurance, explain your options, and help you navigate prior authorization if your plan requires it.